A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine
Clinical trial NCT02291380 · UNKNOWN
Trial details
- NCT number
- NCT02291380
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2019-12-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.